Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer and its relations to the micrometastasis in peripheral blood

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 29, Issue 4, 2009, Pages 462-465

  Jin, Yang ^a   Xiong, Xianzhi ^a   Su, Yuan ^a   Hu, Jianwu ^a   Tao, Xiaonan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cytokeratin 19; Lung neoplasm; Micrometastasis; Vascular endothelial growth factor (VEGF)

Indexed keywords

CYTOKERATIN 19; MESSENGER RNA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KERATIN-19; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68949134287     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-009-0414-8     Document Type: Article

References (26)

1. T. Osaki T. Oyama M. Inoue 2001 Molecular biological markers, an micrometastasis in resected non-small cell lung cancer Prognostic implications. Jap J Thorac Cardiovasc Surg 49 9 545 541
2. X. Jiao M.J. Krasna 2002 Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology Ann Thorac Surg 74 1 278 284
3. F. Le Pimpec-Barthes C. Danel R. Lacave 2005 Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence Eur J Cancer 41 2 306 312
4. G. Buccheri D. Ferrigno 2001 Cytokeratin-derived markers of lung cancer Expert Rev Mol Diagn 1 3 315 322
5. Y. Takahashi Y. Kitadai C.D. Bucana 1995 Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer Cancer Res 55 18 3964 3968
6. H.F. Dvorak J.A. Nagy D. Feng 1999 Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis Curr Top Microbiol Immunol 237 97 132 (Pubitemid 28554861)
7. J. Folkman 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 1 4 6
8. Z. Qu S. Van Ginkel A.M. Roy 2008 Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors Cancer Res 68 15 6232 6240
9. M. Shibuya 2008 Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis BMB Rep 41 4 278 286
10. S.B. Hosch P. Scheunemann J.R. Izbicki 2001 Minimal residual disease in non-small-cell lung cancer Semin Surg Oncol 20 4 278 281
11. A.G. Saad B.Y. Yeap F.B. Thunnissen 2008 Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma Cancer 113 8 2129 2138
12. M.G. Achen S.A. Stacker 2008 Molecular control of lymphatic metastasis Ann N Y Acad Sci 1131 225 234
13. A. Demirkazik H. Akbulut A.F. Ulger 2004 Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer Ann Saudi Med 24 6 473 475
14. R. Futami M. Miyashita T. Nomura 2007 Increased serum vascular endothelial growth factor following major surgical injury J Nippon Med Sch 74 3 223 229
15. M. Aita G. Fasola C. Defferrari 2008 Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer Crit Rev Oncol Hematol 68 3 183 196
16. A. Katsabeki-Katsafli T. Kerenidi K. Kostikas 2008 Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer Lung Cancer 60 2 271 276
17. S. Holdenrieder P. Stieber J. von Pawel 2004 Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer Clin Cancer Res 10 18Pt1 5981 5987
18. M. Cheng Y. Chen X. Yu 2008 Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer BMC Cancer 8 156
19. M.J. Ge Q.C. Wu M. Wang 2005 Detection of disseminated lung cancer cells in regional lymph nodes by assay of CK19 reverse transcriptase polymerase chain reaction and its clinical significance J Cancer Res Clin Oncol 131 10 662 668
20. P. Saintgny S. Coulon M. Kambouchner 2005 Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma Int J Cancer 115 5 777 782
21. S. Kasimir-Bauer N. Schleucher R. Weber 2003 Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival Oncol Rep 10 2 475 482
22. C. Huang D. Liu D. Masuya 2005 Clinical application of biological markers for treatments of resectable non-small-cell lung cancers Br J Cancer 92 7 1231 1239
23. Q. Dong J. Feng J. Huang 2002 Vascular endothelial growth factor promotes hematogenous metastasis of cancer cells in patients with non-small cell lung cancer Zhonghua Zhong Liu Za Zhi (Chinese) 24 2 142 146
24. M. Nishi Y. Abe Y. Tomii 2005 Cell binding isoforms of vascular endothelial growth factor-A (VEGF189) contribute to blood flow-distant metastasis of pulmonary adenocarcinoma Int J Oncol 26 6 1517 1524
25. W.M. Brueckl A. Schoeberl R.M. Wirtz 2008 Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC) J Thorac Oncol 3 3 314 316
26. V.L. Keedy A.B. Sandler 2007 Inhibition of angiogenesis in the treatment of non-small cell lung cancer Cancer Sci 98 12 1825 1830